Salofalk 4 g

Salofalk 4G is a rectal suspension containing mesalazine, used for managing inflammatory bowel conditions. This 4g formulation is designed for targeted relief, available in 7-unit packs from AbbVie Corporation.

Salofalk 4G is primarily used for the treatment of inflammatory bowel conditions, such as ulcerative colitis. This mesalazine suspension is administered rectally to deliver targeted relief directly to the affected areas. Patients often seek Salofalk 4G for managing symptoms associated with these conditions, including what is mesalazine used for in rectal suspensions.

Common effects of Salofalk 4G may include mild rectal discomfort or irritation. Some users report improvements in symptoms such as abdominal pain and diarrhea. Individual responses can vary, and it's important to monitor for any adverse reactions.

Salofalk 4G should be used as directed by a healthcare provider. It is important to follow the prescribed administration instructions to ensure proper use. Patients with known allergies to mesalazine or any of the ingredients should avoid using this product.

Salofalk 4G may interact with certain medications, including other bowel preparations or drugs metabolized by the liver. It is advisable to consult a healthcare provider before combining Salofalk 4G with other treatments. Alcohol and certain foods may also affect its efficacy.